ARTICLE | Management Tracks
Cagnoni now CEO at Flagship’s Laronde
Plus: New commercial head at Valneva, and updates from Aeglea and Viridian
November 18, 2022 12:49 AM UTC
Circular RNA company Laronde Inc. hired Pablo Cagnoni to succeed John Mendlein as CEO. Mendlein is an executive partner at Flagship Pioneering and Laronde’s chair, and has served as the company’s interim CEO since August. Cagnoni was president and CEO at Rubius Therapeutics Inc. (NASDAQ:RUBY) and has been a Laronde board member since November 2021. He is also an executive partner at Flagship.
French vaccine company Valneva SE (Euronext:VLA; NASDAQ:VALN) hired Dipal Patel as chief commercial officer and board member. Patel held roles for over 20 years at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), most recently as global commercial head of Shingrix...